Minoryx is a biotechnology company focused on the discovery and development of novel therapies for orphan diseases. The company's lead product candidate is leriglitazone (MIN-102), an orally bioavailable, brain-penetrant, small molecule that has been granted orphan drug status for the treatment of X-linked adrenoleukodystrophy (X-ALD).

Joan Aymamí

Xavier Barril

Marc Martinell

Minoryx

IDinvest Partners is a self-described leading European venture capital firm.  They focus on investments in technology companies, particularly in the early and growth stages.

IDinvest Partners

Medical Devices Venture is a holding company that develops a portfolio of investments in Med Tech start-ups. The aim is to combine the expertise of researchers in hospital and university settings with industrialization and commercialization capabilities.

Medical Devices Venture

Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management,  with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).  

Metric
Company Name	Minoryx	IDinvest Partners	Medical Devices Venture
Symbol
MSH ID	COM:KURMAPARTNERS	COM:IDINVEST	COM:MEDICALDEVICESVENTURE
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Financial Services & Finance	Healthcare & Health Services
Industry	Biotechnology	Venture Capital	Medical Devices
Country	FR	FR	FR
Stage
Employee Count	31
Website	kurmapartners.com	idinvest.com	medicaldevicesventure.com
LinkedIn	kurma-life-sciences-partners		medical-devices-venture
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:KURMAPARTNERS

Minoryx

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue